Lobe Sciences Ltd.
LOBEF
$0.0407
$0.004813.37%
OTC PK
| 05/31/2025 | 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -42.50% | 15.58% | 71.84% | -559.90% | 29.33% |
| Total Depreciation and Amortization | -- | -- | -- | -100.00% | -1.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -125.72% | -47.32% | -87.95% | 2,052.53% | -298.33% |
| Change in Net Operating Assets | 276.80% | -35.72% | -9.83% | 33.27% | -56.92% |
| Cash from Operations | -13.13% | -45.22% | -1,599.04% | 95.60% | -914.16% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 4,519.87% | -- | -- | -33.19% | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | -- | -- | -- | -- |
| Cash from Financing | 1,875.64% | -- | -- | -33.52% | -- |
| Foreign Exchange rate Adjustments | 143.86% | -296.43% | 1,073.91% | -136.51% | 182.89% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 627,877.78% | 99.42% | -201.45% | 745.00% | 158.25% |